Legal Representation
Attorney
Jared M. Barrett
USPTO Deadlines
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 26, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 26, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 17, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 17, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 19, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 17, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 17, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 18, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 18, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 18, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 23, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 23, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 23, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 15, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 13, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 13, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 13, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jul 20, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 25, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 25, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 5, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 20, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 30, 2021 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Mar 30, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Mar 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 3, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 16, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 16, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 16, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 3, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 18, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 23, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and therapeutic agents modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance
Class 042
Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research
Class 044
Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health
Additional Information
Pseudo Mark
ADITXT REPROGRAMING
Classification
International Classes
005
042
044